Clinical trial · Interventional
Cryotechnique as a Diagnostic and Therapeutic Tool of Endobronchial Tumors
Cryotechnique as a Diagnostic and Therapeutic Tool of Endobronchial Tumors: A Prospective Study
NCT06531265CI-TRIAL-00079312completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was to assess the diagnostic yield and the safety of bronchoscopic cryotechniques in the management of endobronchial tumors.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bronchial Neoplasms | — | UNRESOLVED | — |
| Cryotherapy Effect | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endobronchial cryobiopsy and cryotherapy using flexible bronchoscopy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- study group
- description
- Endobronchial cryobiopsy and cryotherapy using flexible bronchoscopy
- interventionNames
- Procedure: Endobronchial cryobiopsy and cryotherapy using flexible bronchoscopy
Primary outcomes (2)
- measure
- Diagnostic yield
- timeFrame
- within 10 days
- description
- The recording of histopathological diagnosis as revealed by cryobiopsy
- measure
- Recanalization Success
- timeFrame
- one day following the procedure
- description
- The measurement of degree of airway recanalization through bronchoscopic evaluation
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria:
* patients with radiologically suspected endobronchial masses
Exclusion Criteria:
* Patients with contraindications to bronchoscopy.
* uncorrected coagulopathy (if the international normalized ratio (INR) is more than 1.5).
* severe refractory hypoxemia (even after administering the highest possible dose of oxygen, the partial pressure of oxygen ("PaO2") stays below 70 mm Hg.
* hypoventilation with hypercapnia (type 2 respiratory failure).
* severe pulmonary hypertension \> 55 mmHg by echocardiography.
* hemodynamic instability.References
Publications (0)
Data not yet available
No reference posted for this study.